Paid Clinical Trials in Myrtle Beach, SC

As of July 2026, 81 paid clinical trials are recruiting in Myrtle Beach, South Carolina. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.

Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 1, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

77 clinical trials

↓ Download CSV

Study of HLD-0915 in Patients With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

11 locations incl. Denver

Sponsor: Halda Therapeutics OpCo, Inc.

Sex: Male·Age: 18+

Code: NCT06800313·Phase 1, Phase 2·Recruiting

Apply to this trial

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

for Non-muscle-invasive Bladder Cancer

11 locations incl. Little Rock

Sponsor: Aura Biosciences

Sex: All·Age: 18+

Code: NCT05483868·Phase 1·Recruiting

Apply to this trial

The ArtixASCEND Study

for Acute Lower Limb Arterial Occlusion

14 locations incl. New Haven

Sponsor: Inari Medical

Sex: All·Age: 18+

Code: NCT07135895·Recruiting

Apply to this trial

A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)

for Advanced Renal Cell Carcinoma (RCC)

Drug: Cabozantinib

18 locations incl. Palo Alto

Sponsor: Bristol-Myers Squibb

Sex: All·Age: 18+

Code: NCT07293351·Phase 1, Phase 2·Recruiting

Apply to this trial

Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

for Clear Cell Renal Cell Carcinoma

10 locations incl. Duarte

Sponsor: Neomorph, Inc

Sex: All·Age: 18+

Code: NCT07300241·Phase 1·Recruiting

Apply to this trial

A Clinical Study of KTX-2001 in Subjects With Metastatic Castration-Resistant Prostate Cancer (STRIKE-001)

for Metastatic Castration-resistant Prostate Cancer

13 locations incl. San Francisco

Sponsor: K36 Therapeutics, Inc.

Sex: Male·Age: 18+

Code: NCT07103018·Phase 1·Recruiting

Apply to this trial

BEACON-1: Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)

for Solid Tumor Cancer

10 locations incl. San Francisco

Sponsor: Avenzo Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT07193511·Phase 1, Phase 2·Recruiting

Apply to this trial

A Phase 2 Study to Evaluate the Effects of ASP5541 in Participants With Prostate Cancer

for Prostate Cancer

10 locations incl. Huntsville

Sponsor: Astellas Pharma Global Development, Inc.

Sex: Male·Age: 18+

Code: NCT07005154·Phase 2·Recruiting

Apply to this trial

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG

10 locations incl. Chicago

Sponsor: Theralase® Technologies Inc.

Sex: All·Age: 18+

Code: NCT03945162·Phase 2·Recruiting

Apply to this trial

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

for Metastatic Castration-resistant Prostate Cancer

9 locations incl. La Jolla

Sponsor: Daiichi Sankyo

Sex: Male·Age: 18+

Code: NCT07244341·Phase 1·Recruiting

Apply to this trial

Study Evaluating the Safety, Tolerability, and Efficacy of Xaluritamig in Combination With Androgen Receptor Pathway Inhibitors in Participants With Metastatic Hormone-sensitive Prostate Cancer

for Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

8 locations incl. San Francisco

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT07140900·Phase 1·Recruiting

Apply to this trial

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

for Prostate Cancer Patients Treated by Radiotherapy

7 locations incl. Peoria

Sponsor: Candel Therapeutics, Inc.

Sex: Male·Age: 18+

Code: NCT07332000·Phase 2·Recruiting

Apply to this trial

A Study of GEN1106 in Participants With Solid Tumors

for Solid Tumors

4 locations incl. New Haven

Sponsor: Genmab

Sex: All·Age: 18+

Code: NCT07416123·Phase 1·Recruiting

Apply to this trial

A Study to Find Out if Enfortumab Vedotin Given With Pembrolizumab Helps People With Muscle-invasive Bladder Cancer Keep Their Bladder

for Muscle-invasive Bladder Cancer

9 locations incl. Little Rock

Sponsor: Astellas Pharma Global Development, Inc.

Sex: All·Age: 18+

Code: NCT07475806·Phase 2·Recruiting

Apply to this trial

Phase 1 Study of ACE-232 to Treat Patients With Metastatic Castration-Resistant Prostate Cancer

for Prostate Cancer (Adenocarcinoma)

8 locations incl. La Jolla

Sponsor: Acerand Therapeutics (Hong Kong) Limited

Sex: Male·Age: 18+

Code: NCT06801236·Phase 1·Recruiting

Apply to this trial

Efficacy and Safety of Intravesical TARA-002 Compared With Investigator's Choice of Intravesical Chemotherapy in Participants With BCG-naïve High-grade Non-muscle Invasive Bladder Cancer

for Bladder (Urothelial, Transitional Cell) Cancer

5 locations incl. Queen Creek

Sponsor: Protara Therapeutics

Sex: All·Age: 18+

Code: NCT07480356·Phase 3·Recruiting

Apply to this trial

A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer

for Metastatic Castration-Resistant Prostate Cancer

5 locations incl. San Francisco

Sponsor: Hoffmann-La Roche

Sex: Male·Age: 18+

Code: NCT07287150·Phase 2·Recruiting

Apply to this trial

TulmiSTAR-02: A Phase I/II Open-label Study of Tulmimetostat in Combination With Darolutamide vs. Darolutamide, and Tulmimetostat With Abiraterone in Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

for Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)

Drug: Tulmimetostat

8 locations incl. Birmingham

Sponsor: Novartis Pharmaceuticals

Sex: Male·Age: 18+

Code: NCT07190300·Phase 1, Phase 2·Recruiting

Apply to this trial

A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003)

for Bladder Cancer

2 locations incl. Bakersfield

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18+

Code: NCT07222488·Phase 1, Phase 2·Recruiting

Apply to this trial

Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

for Prostate Cancer

7 locations incl. San Francisco

Sponsor: Amgen

Sex: Male·Age: 18+

Code: NCT06613100·Phase 1·Recruiting

Apply to this trial

FK-PC101 as Adjuvant Therapy for Men With High-Risk Prostate Cancer

for Prostate Cancer (Adenocarcinoma)

3 locations incl. Chicago

Sponsor: Cellvax Therapeutics Inc

Sex: Male·Age: All ages

Code: NCT06636682·Phase 2·Recruiting

Apply to this trial

Enzalutamide Implants (Enolen) in Patients With Prostate Cancer

for Prostate Adenocarcinoma

7 locations incl. Chicago

Sponsor: Alessa Therapeutics Inc.

Sex: Male·Age: 21+

Code: NCT06257693·Phase 1·Recruiting

Apply to this trial

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

for Stage I Breast Cancer

812 locations incl. Easton

Sponsor: NRG Oncology

Sex: All·Age: 50 - 70

Code: NCT04852887·Phase 3·Recruiting

Apply to this trial

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

for Castration Levels of Testosterone

334 locations incl. Gilbert

Sponsor: SWOG Cancer Research Network

Sex: Male·Age: 18+

Code: NCT03678025·Phase 3·Recruiting

Apply to this trial

ENdoluminal LIGHT ActivatED Treatment of Upper Tract Urothelial Cancer (ENLIGHTED) Study

for Transitional Cell Cancer of Renal Pelvis and Ureter

12 locations incl. Irvine

Sponsor: Steba Biotech S.A.

Sex: All·Age: 18+

Code: NCT04620239·Phase 3·Recruiting

Apply to this trial

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

for Metastatic Castration-resistant Prostate Cancer

24 locations incl. Dothan

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07611110·Phase 3·Recruiting

Apply to this trial

A Trial to Learn How Safe AZD9750 is and How Well it Works in People With Metastatic Prostate Cancer When Given With or Without Other Anticancer Drugs

for Prostate Cancer

8 locations incl. Duarte

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT07336446·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study to Investigate Efficacy and Safety of AZD1163 in Participants With Rheumatoid Arthritis

for Rheumatoid Arthritis

28 locations incl. Glendale

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07276581·Phase 2·Recruiting

Apply to this trial

Study of AZD0516 as Monotherapy and in Combination in Participants With Metastatic Prostate Cancer

for Metastatic Prostate Cancer

11 locations incl. Fayetteville

Sponsor: AstraZeneca

Sex: Male·Age: 18 - 130

Code: NCT07181161·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma

for Urothelial Cancer

38 locations incl. Fullerton

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT07129993·Phase 2, Phase 3·Recruiting

Apply to this trial

A Phase I/II Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma

for B-cell Non-Hodgkin Lymphoma

8 locations incl. Irvine

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07123454·Phase 1, Phase 2·Recruiting

Apply to this trial

A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation

for Prostate Cancer

Drug: Saruparib

42 locations incl. Phoenix

Sponsor: AstraZeneca

Sex: Male·Age: 18+

Code: NCT06952803·Phase 3·Recruiting

Apply to this trial

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

for Cardiovascular Disease

315 locations incl. Athens

Sponsor: AstraZeneca

Sex: All·Age: 18+

Code: NCT07000357·Phase 3·Recruiting

Apply to this trial

Evaluating the Effects of Tasimelteon vs. Placebo in Treating Pediatric Insomnia

for Insomnia Disorder

21 locations incl. Dothan

Sponsor: Vanda Pharmaceuticals

Sex: All·Age: 2 - 17

Code: NCT06953869·Phase 3·Recruiting

Apply to this trial

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

for Solid Tumor

13 locations incl. Denver

Sponsor: Biohaven Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT06874335·Phase 1·Recruiting

Apply to this trial

A Study of GSK5764227 in Participants With Advanced Solid Tumors (EMBOLD)

for Neoplasms

15 locations incl. Stanford

Sponsor: GlaxoSmithKline

Sex: All·Age: 18+

Code: NCT06551142·Phase 1·Recruiting

Apply to this trial

Study of Zanzalintinib in Combination With Immuno-Oncology Agents in Participants With Solid Tumors

for Renal Cell Carcinoma (RCC)

46 locations incl. Phoenix

Sponsor: Exelixis

Sex: All·Age: 18+

Code: NCT05176483·Phase 1·Recruiting

Apply to this trial